GEMPHARMATECH: Overseas business focuses on the delivery of efficacy reports, "reciprocal tariffs" have little impact on the company

According to GEMPHARMATECH, the company is continuously advancing its internationalization strategy, accelerating the pace of expansion into overseas markets, and successfully building an overseas sales network covering multiple countries and regions in the Asia-Pacific, Europe, and the Americas. The main customers are relatively evenly distributed across North America, Europe, and the Asia-Pacific regions. At the same time, in the aforementioned non-core areas, the company has effectively enhanced the coverage and expansion speed of overseas markets through agents. GEMPHARMATECH stated that currently, the company's overseas business mainly revolves around the delivery of efficacy reports, and due to the uniqueness of its business structure, it is less sensitive to "equivalent tariffs." Meanwhile, GEMPHARMATECH is actively deploying the construction of overseas facilities. Through this initiative, the company aims to enhance its market competitiveness and strengthen its ability to respond to market risks, laying a solid foundation for the company's long-term development